当前位置:首页 > 国际动态>正文
FDA Expands Pfizer Booster Eligibility to Kids Ages 12 to 15
2022-01-05 15:04:06 来源:Daguan Keweiwei
According to foreign media reports, the Food and Drug Administration(FDA) expanded eligibility for Pfizer and BioNTech booster shots to children ages 12 to 15 years old.
The FDA also shortened the time between the second Pfizer dose and the booster shot to five months, down from six months. The agency also authorized a third vaccine dose as part of the primary series of shots for children ages 5 through 11 who have compromised immune systems.
Dr. Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention, has encouraged everyone who is eligible to receive a booster dose.
About Pfizer
Pfizer was founded in 1849 and has a history of more than 170 years. Headquartered in New York, USA, Pfizer is a science-based, innovative and patient-first biopharmaceutical company. Pfizer's goal is to "bring breakthrough innovations that change patients' lives."
On the ranking of “The First Daguan · Keweiwei World Brand Value Top 900" released on March 14, 2021, Pfizer's brand value was 876.166 billion RMB, ranking the 12th.
作者:Nan
相关新闻全部阅读